ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print June 28, 2006
Eur Respir J 2006, doi:10.1183/09031936.06.00028406
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
28/5/920    most recent
09031936.06.00028406v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meliton, A.Y.
Right arrow Articles by Leff, A.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meliton, A.Y.
Right arrow Articles by Leff, A.R.


ORIGINAL ARTICLE

PDE4-inhibition on {beta}2-integrin Adhesion Caused by LTB4 and TNF{alpha} in Human Neutrophils

A.Y. Meliton 1, N.M. Muñoz 1, A. Lambertino 1, E. Boetticher 1, J. Learoyd 1, X. Zhu 1, A.R. Leff 2*

1 Section of Pulmonary and Critical Care Medicine, Dept of Medicine
2 Section of Pulmonary and Critical Care Medicine, Dept of Medicine; and Depts of Neurobiology Pharmacology and Physiology and Committees on Molecular Medicine, Clinical Pharmacology, and Cell Physiology, The University of Chicago, Chicago, Illinois 60637.

* To whom correspondence should be addressed. E-mail: aleff{at}medicine.bsd.uchicago.edu.


   Abstract

Phosphodiesterase (PDE)4-inhibition attenuates neutrophilic inflammation in chronic obstructive pulmonary disease.

The objective of this study was to examine the efficacy and mechanism by which PDE4-inhibition blocks adhesion of {beta}2-integrin to endothelial counterligand.

Neutrophils (PMN)s were isolated from humans receiving no medications. Adhesion was analyzed by myeloperoxidase activity. The effects of cilomilast±salmeterol on a) surface CD11b expression, b) adhesion, c) intracellular cAMP concentration, and d) ERK-1/2 mediated group IVA-phospholipase A2 (gIVA-PLA2) phosphorylation caused by LTB4 or TNF{alpha} activation were determined.

Either cilomilast or rolipram±salmeterol caused concentration-related blockade of LTB4-induced adhesion to counterligand, but had no effect on TNF{alpha}-activated PMNs. 1µM cilomilast+0.1µM salmeterol caused comparable increase in intracellular cAMP concentration for PMNs activated with LTB4 and TNF{alpha}. Upregulation of surface CD11b expression and ERK-1/2 phosphorylation were blocked by cilomilast or rolipram±salmeterol for PMN activated by LTB4, but not for cells stimulated by TNF{alpha}. Cilomilast±salmeterol also blocked gIVA-PLA2 phosphorylation caused by LTB4 but not TNF{alpha}.

We demonstrate that both LTB4 and TNF{alpha} upregulate cAMP. However cAMP does not block {beta}2-integrin adhesion caused by TNF{alpha}. We conclude that TNF{alpha} prevents inhibition of gIVA-PLA2 activation, which is essential for {beta}2-integrin adhesion in PMN.

Keywords:  Adhesion, inflammation, neutrophils, phosphodiesterase-4




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. M. Munoz, A. Y. Meliton, L. N. Meliton, S. M. Dudek, and A. R. Leff
Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice
Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L879 - L887.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Y. Meliton, N. M. Munoz, X. Zhu, and A. R. Leff
Attenuated translocation of group IVa phospholipase A2 and up-regulated annexin-1 synthesis by glucocorticoid blocks {beta}2-integrin adhesion in neutrophils
J. Leukoc. Biol., February 1, 2008; 83(2): 344 - 351.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the European Respiratory Society.